ARTES Biotechnology GmbH

ARTES Biotechnology – recombinant protein from microbial expression systems

ARTES is an expert in the field of developing cell lines and processes from yeast and bacteria for customer´s target of choice – being a vaccine, a biopharmaceutical, a biosimilar and/or an enzyme. Our high yield expression platforms and our expertise in troubleshooting for difficult-to-express proteins support your manufacturing processes.

Our expression platforms are complemented by unique virus-like particle (VLP) technologies for antigen presentation and vaccine development.

All platform technologies (cell lines and antigen presentation) ensure freedom-to-operate and are protected by patents and trade secrets. ARTES is available to negotiate exclusive license terms.

ARTES provides access to a broad spectrum of ready-to-transfer processes enabling local manufacturing at your site.

On top of our service offer, we produce and sell a line of antigens, enzymes, and functional proteins for your specific lab use.

We contribute more than 20 years of business experience, a track record of products developed for and marketed by our clients as well as safe, reliable, and highly competitive microbial production platforms.